PPT1 and infantile neuronal ceroid lipofuscinosis: As the inactive mutations in PPT1 gene lead to fatal neurodegeneration in infantile neuronal cerebral lipofuscinosis (INCL) patients, the second generation of chloroquine derivatives that penetrate the blood-brain barrier are more likely to have CNS toxicity in the future [31].